James Todd, MD
Orthopaedic Surgery · Terrytown, LANPI 1558306050
Payments from drug & device makers
Across 43 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$142
- Organogenesis Inc.$89
- Medtronic$88
- Convatec Inc.$77
- Fidia Pharma USA Inc.$76
- Pacira Therapeutics, Inc.$53
- plus $467 from 17 others
What the payments were for
- Speaking & faculty fees$323%
- Food & beverage$95997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 3 | $142 |
| Organogenesis Inc. | 2 | $89 |
| Medtronic(2 entities) | 2 | $88 |
| Convatec Inc. | 3 | $77 |
| Fidia Pharma USA Inc. | 4 | $76 |
| Pacira Therapeutics, Inc. | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 3 | $52 |
| Boston Scientific | 1 | $48 |
| Nevro Corp. | 2 | $44 |
| Baudax Bio Inc. | 3 | $42 |
| Endo Pharmaceuticals Inc. | 3 | $40 |
| Globus Medical | 1 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Bioventus LLC | 2 | $25 |
| Amgen | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Endo USA, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Esaote North America, Inc. | 1 | $15 |
| ERMI LLC | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$991 in reported general payments places this provider in the 30th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 68 | $672 |
| Methylprednisolone | 60 | $475 |
| Diclofenac Sodium | 11 | $307 |
| Tramadol Hcl | 32 | $179 |
| Meloxicam | 25 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Terrytown
- Neil DuplantierTerrytown$145K
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
- Neil MakiThibodaux$620K
- Timmothy RandellAlexandria$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.